Project Grant R21EY036545

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $193K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Durham, NC 27708, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development of a robotically-aligned optical coherence tomography (RAOCT) system capable of automatically measuring a retinal biomarker, the outer nuclear layer (ONL) thickness, which cannot be reliably identified using standard OCT devices. The $215,454 award to Duke University aims to leverage the micrometer-scale control of the RAOCT system's sample beam to enable...
The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (Massachusetts General Hospital) to develop new "Auto-Sensing, Instantaneous Adaptive Ranging Optical Coherence Tomography (OCTA)" technology. This technology aims to expand the imaging depth range of OCTA systems, enabling improved visualization of the critical peripheral retinal microvasculature. The project will leverage advances in integrated...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) to New York University School of Medicine provides $673,747 to develop a visible-to-near-infrared spanning optical coherence tomography (OCT) system capable of imaging retinal structures at a resolution of up to 0.5 microns. The goal is to leverage this advanced OCT technology to study the spatiotemporal relationship of key biomarkers such as macular pigments and retinal pigment epithelium melanosomes, and...
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $300,001 Project Grant to Kineolabs, Inc. in Billerica, MA. The objective of this 1-year grant, which runs from July 1, 2025 to June 30, 2026, is to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. This system is intended for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...
The National Eye Institute (NEI) awarded a $179,964 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, Irvine (UCI) with a project period from March 1, 2025 to July 10, 2029. The project aims to develop innovative deep learning-based retinal optical coherence tomography (OCT) biomarkers to improve the diagnosis and management of optic neuropathies, a group of eye diseases that primarily target the optic nerve and frequently result in...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $881,796 to Siloam Vision, Inc. to develop two advanced, laser-based, AI-enabled retinal imaging systems. The key innovations are: A wider field-of-view camera design that can be paired with either a scanning laser ophthalmoscope (SLO) or optical coherence tomography (OCT) system, offering 2D or 3D imaging, respectively. This aims to address an unmet need in retinopathy...
The National Eye Institute (NEI) has awarded a $592,457 Project Grant (CFDA 93.867 - Vision Research) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to characterize the response features of intrinsically photosensitive retinal ganglion cells (ipRGCs) and understand how they shape signals sent from ipRGCs to the brain. The award period is from September 30, 2024 to August 31, 2029. The research aims to strengthen the basic understanding of ipRGCs, sensory...
The National Eye Institute (NEI) awarded a $417,162 Project Grant under the Vision Research program (CFDA 93.867) to the University of Houston System to develop and apply a polarization-sensitive swept source optical coherence tomography (PS-SSOCT) system for 3D mapping of the birefringent properties of the posterior eye in a non-human primate model. The goal is to quantify changes in birefringence within the retina, optic nerve head, and lamina cribrosa in response to changes in intraocular...

The National Eye Institute (NEI) awarded a $193,168 Project Grant (CFDA 93.867 Vision Research) to Duke University to develop a novel, auto-aligning hand-held optical coherence tomography (OCT) and OCT angiography (OCTA) probe for routine and repeatable high-quality retinal imaging in infants and children. The research aims to address the challenges associated with obtaining consistent OCT and OCTA data capture in uncooperative pediatric patients. The expected outcomes include a set of technologies capable of providing quantifiably reproducible retinal structure and angiographic imaging in both adult and pediatric subjects. The award period is from Sep 1, 2024 to Aug 31, 2026.

Generated 7/1/25, 2:08 AM